Navigation Links
Alpha-1 Foundation President to Give Keynote Address at 53rd Annual Respiratory Congress of the AARC Foundation and Activities
Date:10/25/2007

MIAMI, Oct. 25 /PRNewswire/ -- John W. Walsh, president of the COPD Foundation, will give the keynote address at the 53rd International Respiratory Congress of the American Association for Respiratory Care (AARC) Dec. 1 in Orlando, FL. AARC is a 43,000-member association representing respiratory therapists involved in the treatment and care of individuals of all ages who suffer a range of respiratory illness, including asthma, cystic fibrosis, and Chronic Obstructive Pulmonary Disease (COPD), the fourth largest cause of death in the United States.

Walsh and the COPD Foundation have been involved as key partners with the AARC and other organizations in the NIH, National Heart, Lung & Blood Institute (NHLBI) "Learn More, Breathe Better" campaign, the first-ever national COPD awareness and education campaign.

As part of that NHLBI campaign, the COPD Foundation and AARC send Mobile Spirometry Units (MSU) all over the United States, to health fairs, fitness expositions and other events, offering free spirometry to encourage early diagnosis of those at risk for COPD and to inform them about Alpha-1 Antitrypsin Deficiency. The AARC has collaborated and ensures that respiratory therapists meet the MSU at each location to perform spirometries and answer questions.

Walsh recently lobbied Congress with Grace Anne Dorney Koppel, a patient advocate for the "Learn More, Breathe Better" campaign, and AARC Executive Director Sam Giordano, urging that pulmonary rehabilitation be established as a Medicare benefit.

Well-known as an inspirational and motivational patient speaker, Walsh has COPD related to Alpha-1 Antitrypsin Deficiency, the most common known genetic risk factor for COPD. Diagnosed with Alpha-1 in 1989, he is also the co- founder, President and CEO of the Alpha-1 Foundation in Miami, FL. He regularly testifies before Congress and advisory groups as a patient advocate.

In 2002, he was recognized by the FDA with the Commissioner's Special Citation for his work in pioneering collaborations in orphan drug development. He is the Chair of the International COPD Coalition and a member of the US COPD Coalition Executive Committee; Immediate Past Chair and member of the American Thoracic Society's Public Advisory Roundtable; 2005-2006 Chair of the National Health Council's Board of Directors; a member of the American Lung Association's National Action Panel on Lung Disease; and was the 2004-2005 Presidential Appointee of the American Thoracic Society's Board of Directors.

Some 3,000 respiratory therapists are expected to attend the 53rd International Congress in Orlando.

About the COPD Foundation:

The COPD Foundation is dedicated to developing and supporting programs which improve the quality of life through research, education, early diagnosis, and enhanced therapy for persons whose lives are impacted by Chronic Obstructive Pulmonary Disease.

For more information, please visit http://www.copdfoundation.org.

About the Alpha-1 Foundation: The mission of the Alpha-1 Foundation is to provide the leadership and resources that will result in increased research, improved health, worldwide detection, and a cure for Alpha-1 Antitrypsin Deficiency. For more information, please visit: http://www.alphaone.org. Available Topic Expert(s): For information on the listed expert(s), click appropriate link. Mark Brantly http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=54431 Charlie Strange http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=54427 Holly Miller http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=54424 Michael Campos http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=54425 Adam Wanner http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=54278 Robert Sandhaus http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=54274 John Walsh http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=54964


'/>"/>
SOURCE Alpha-1 Foundation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Woodruff Foundation Grant To Support Doctorate Of Nursing Practice Program
2. Kalam To Lay Foundation Of Vellore Research Center
3. Nippon Foundation To Help Leprosy Patients
4. Parents Launch SV40 Cancer Foundation In Memory of Son
5. Cancer Aid And Research Foundation: Offering Endless Hope To Cancer Patients
6. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
7. PM Launches Healthcare Foundation For India
8. Prime Minister Manmohan Singh, Flags Off Public Health Foundation of India
9. Gates Foundation to donate USD 104 million to TB Alliance
10. MoU for HIV/AIDS Signed by Nigeria and Clinton Foundation
11. Gates Foundation Adopts Fight against Encephalitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... ... ... “The Trials I Face to Receive God’s Grace”: a mesmerizing take ... goals to better one’s life through God. “The Trials I Face to Receive God’s ... wrong places, found a love for writing. Green feels that expressing his feelings through ...
(Date:9/20/2017)... ... ... Houston, Texas, investment firm CORDA Investment Management, LLC, believes in giving back. ... work and rolled up their sleeves to help with relief efforts. The team picked ... process of rebuilding. , CORDA founder Bonner C. Barnes notes that investment management firms ...
(Date:9/20/2017)... ... September 20, 2017 , ... “The Foggy Road to Moorwick”: the adventures of a young ... creation of published author, Jeanine Liston, a busy mother of five who used her time ... been writing this book for over twenty years. It was a way to give ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... “Monique”: ... into uncomfortable situations. “Monique” is the creation of published author, Colleen Crispi, has owned ... Since then Crispi has been involved in real estate and cooking. , “The ...
(Date:9/19/2017)... ... September 19, 2017 , ... DeSola Group, ... marketing leader, Denise Flannery, to its strategic advisory and client development team. ... will work with clients across different industries to develop and implement market-justified strategies, ...
Breaking Medicine News(10 mins):
(Date:9/9/2017)... 9, 2017  Eli Lilly and Company (NYSE: ... endpoint data for lasmiditan, an investigational, oral, first-in-class molecule ... significant improvements compared to placebo in the Phase 3 ... the 18th Congress of the International Headache Society (IHC) ... data presented today demonstrate lasmiditan,s potential to reduce pain ...
(Date:9/7/2017)... Caris Life Sciences, a leading innovator ... of precision medicine, today announced results from two ... molecular profiling approach in guiding therapeutic strategies in ... (CGP+) with Caris Molecular Intelligence ® to ... level, leading to more therapeutic options and improved ...
(Date:9/7/2017)... , Sept. 7, 2017   BioLife Solutions , Inc. ... marketer of proprietary clinical grade cell and tissue hypothermic ... that Mike Rice , President and CEO, will be ... Rodman & Renshaw 19 th Annual Global ... time (12:25 p.m. Pacific time). The conference is being held ...
Breaking Medicine Technology: